Self-Expanding Metal Stent (SEMS): an innovative rescue therapy for refractory acute variceal bleeding

Background: Acute variceal bleeding (AVB) is a life-threatening complication of liver cirrhosis or less commonly splenic vein thrombosis. Pharmacological and endoscopic interventions are cornerstones in the management of variceal bleeding but may fail in 10 – 15 % of patients. Rescue therapy with balloon tamponade (BT) or transjugular intrahepatic portosystemic shunt (TIPS) may be required to control refractory acute variceal bleeding effectively but with some limitations. The self-expanding metal stent (SEMS) is a covered, removable tool that can be deployed in the lower esophagus under endoscopic guidance as a rescue therapy to achieve hemostasis for refractory AVB.

Aims: To evaluate the technical feasibility, efficacy, and safety of SEMS as a rescue therapy for AVB.

Methods: In this review article, we have performed an extensive literature search summarizing case reports and case series describing SEMS as a rescue therapy for AVB. Indications, features, technique, deployment, success rate, limitations, and complications are discussed.

Results: At present, 103 cases have been described in the literature. Studies have reported 97.08 % technical success rates in deployment of SEMS. Most of the stents were intact for 4 – 14 days with no major complications reported. Stent extraction had a success rate of 100 %. Successful hemostasis was achieved in 96 % of cases with only 3.12 % found to have rebleeding after placement of SEMS. Stent migration, which was the most common complication, was observed in 21 % of patients.

Conclusion: SEMS is a safe and effective alternative approach as a rescue therapy for refractory AVB.

• References

• 1 Biecker E. Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management. World J Gastroenterol 2013; 19: 5035-5050
• 2 D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22: 332-354
• 3 D'Amico G, De Franchis R. Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612
• 4 Thomopoulos K, Theocharis G, Mimidis K et al. Improved survival of patients presenting with acute variceal bleeding. Prognostic indicators of short- and long-term mortality. Dig Liver Dis 2006; 38: 899-904
• 5 Chalasani N, Kahi C, Francois F et al. Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003; 98: 653-659
• 6 Vlavianos P, Mac Mathuna P, Williams R et al. Splanchnic and systemic haemodynamic response to volume changes in patients with cirrhosis and portal hypertension. Clin Sci (Lond) 1999; 96: 475-481
• 7 Kravetz D, Bosch J, Arderiu M et al. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting. Hepatology 1989; 9: 808-814
• 8 Ferguson JW, Tripathi D, Hayes PC. Review article: the management of acute variceal bleeding. Aliment Pharmacol Ther 2003; 18: 253-262
• 9 Bernard B, Grangé JD, Khac EN et al. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology 1999; 29: 1655-1661
• 10 Soares-Weiser K, Brezis M, Tur-Kaspa R et al. Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. Cochrane Database Syst Rev 2002; 2: CD002907
• 11 Levacher S, Letoumelin P, Pateron D et al. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995; 346 : 865-868
• 12 Calès P, Masliah C, Bernard B et al. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 2001; 344: 23-28
• 13 Avgerinos A, Nevens F, Raptis S et al. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: the European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomized trial. Lancet 1997; 350 : 1495-1499
• 14 Lo GH, Lai KH, Ng WW et al. Injection sclerotherapy preceded by esophageal tamponade versus immediate sclerotherapy in arresting active variceal bleeding: a prospective randomized trial. Gastrointest Endosc 1992; 38: 421-424
• 15 Hsu YC, Chung CS, Tseng CH et al. Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage. J Gastroenterol Hepatol 2009; 24: 1294-1299
• 16 Sung JJ, Chung SC, Yung MY et al. Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995; 346 : 1666-1669
• 17 Bañares R, Albillos A, Rincón D et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002; 35: 609-615
• 18 Besson I, Ingrand P, Person B et al. Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995; 333: 555-560
• 19 Zuberi BF, Baloch Q. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis. Am J Gastroenterol 2000; 95: 768-771
• 20 D’Amico G, Pietrosi G, Tarantino I et al. Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: a Cochrane meta-analysis. Gastroenterology 2003; 124: 1277-1291
• 21 Boyer TD, Henderson JM, Heerey AM. DIVERT Study Group et al. Cost of preventing variceal rebleeding with transjugular intrahepatic portal systemic shunt and distal splenorenal shunt. J Hepatol 2008; 48: 407-414
• 22 Sengstaken RW, Blakemore AH. Balloon tamponade for the control of hemorrhage from esophageal varices. Ann Surg 1950; 131: 781-789
• 23 Panés J, Terés J, Bosch J et al. Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci 1988; 33: 454-459
• 24 Jaramillo JL, de la Mata M, Miño G et al. Somatostatin versus Sengstaken balloon tamponade for primary haemostasis of bleeding esophageal varices. A randomized pilot study. J Hepatol 1991; 12: 100-105
• 25 Bosch J, Berzigotti A, Garcia-Pagan JC et al. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008; 48 (Suppl. 01) 68-S92
• 26 Chojkier M, Conn HO. Esophageal tamponade in the treatment of bleeding varices. A decade progress report. Dig Dis Sci 1980; 25: 267-272
• 27 D’Amico M, Berzigotti A, Garcia-Pagan JC. Refractory acute variceal bleeding: what to do next?. Clin Liver Dis 2010; 14: 297-305
• 28 Chong CF. Esophageal rupture due to Sengstaken-Blakemore tube misplacement. World J Gastroenterol 2005; 11: 6563-6565
• 29 Collyer TC, Dawson SE, Earl D. Acute upper airway obstruction due to displacement of a Sengstaken-Blakemore tube. Eur J Anaesthesiol 2008; 25: 341-342
• 30 Rikkers LF. The changing spectrum of treatment for variceal bleeding. Ann Surg 1998; 228: 536-546
• 31 Willson PD, Kunkler R, Blair SD et al. Emergency oesophageal transection for uncontrolled variceal haemorrhage. Br J Surg 1994; 81: 992-995
• 32 Burroughs AK, Hamilton G, Phillips A et al. A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 1989; 321: 857-862
• 33 Huizinga WK, Angorn IB, Baker LW. Esophageal transection versus injection sclerotherapy in the management of bleeding esophageal varices in patients at high risk. Surg Gynecol Obstet 1985; 160: 539-546
• 34 Adam R, Diamond T, Bismuth H. Partial portocaval shunt: renaissance of an old concept. Surgery 1992; 111: 610-616
• 35 Darling 3rd RC, Shah DM, Chang BB et al. Long-term follow-up of poor-risk patients undergoing small-diameter portocaval shunts. Am J Surg 1992; 164: 225-227 ; discussion 227-228
• 36 Boyer TD, Haskal ZJ. American Association for the Study of Liver Diseases. The role of transjugular intrahepatic portosystemic shunt in the management of portal hypertension. Hepatology 2005; 41: 386-400
• 37 Sanyal AJ, Freedman AM, Shiffman ML et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 1994; 20: 46-55
• 38 Hubmann R, Bodlaj G, Czompo M et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy 2006; 38: 896-901
• 39 Matull WR, Cross TJ, Yu D et al. A removable covered self-expanding metal stent for the management of Sengstaken-Blakemore tube-induced esophageal tear and variceal hemorrhage. Gastrointest Endosc 2008; 68: 767-768 (discussion 768)
• 40 Zehetner J, Shamiyeh A, Wayand W et al. Results of a new method to stop acute bleeding from esophageal varices: implantation of a self-expanding stent. Surg Endosc 2008; 22: 2149-2152
• 41 Dechene A, Adamzik M, Gerken G et al. Acute bronchial obstruction following esophageal stent implantation for variceal bleeding. Endoscopy 2009; 41: E146-E147
• 42 Wright G, Lewis H, Hogan B et al. A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc 2010; 71: 71-78
• 43 Mishin I, Ghidirim G, Dolghii A et al. Implantation of self-expanding metal stent in the treatment of severe bleeding from esophageal ulcer after endoscopic band ligation. Dis Esophagus 2010; 23: E35-E38
• 44 Dechêne A, El Fouly AH, Bechmann LP et al. Acute management of refractory variceal bleeding in liver cirrhosis by self-expanding metal stents. Digestion 2012; 85: 185-191
• 45 Holster IL, Kuipers EJ, van Buuren HR et al. Self-expandable metal stents as definitive treatment for esophageal variceal bleeding. Endoscopy 2013; 45: 485-488
• 46 Fierz FC, Kistler W, Stenz V et al. Treatment of esophageal variceal hemorrhage with self-expanding metal stents as a rescue maneuver in a Swiss multicentric cohort. Case Rep Gastroenterol 2013; 7: 97-105
• 47 Zakaria MS, Hamza IM, Mohey MA et al. The first Egyptian experience using new self-expandable metal stents in acute esophageal variceal bleeding: pilot study. Saudi J Gastroenterol 2013; 19: 177-181
• 48 Maufa F, Al-Kawas FH. Role of self-expandable metal stents in acute variceal bleeding. Int J Hepatol 2012; 2012: 418369
• 49 Escorsell A, Bosch J. Self-expandable metal stents in the treatment of acute esophageal variceal bleeding. Gastroenterol Res Pract 2011; 2011: 910986
• 50 Seewald S, Mendoza G, Seitz U et al. Variceal bleeding and portal hypertension: has there been any progress in the last 12 months?. Endoscopy 2003; 35: 136-144
• 51 Sakai P, Maluf Filho F, Melo JM et al. Is endoscopic band ligation of esophageal varices contraindicated in Child-Pugh C patients?. Endoscopy 1994; 26: 511-512
• 52 Van Vlierberghe H, De Vos M, Hautekeete M et al. Severe bleeding following endoscopic variceal ligation: should EVL be avoided in Child C patients?. Acta Gastroenterol Belg 1999; 62: 175-177
• 53 Farivar AS, Vallières E, Kowdley KV et al. Airway obstruction complicating esophageal stent placement in two post-pneumonectomy patients. Ann Thorac Surg 2004; 78: e22-e23
• 54 Libby ED, Fawaz R, Leano AM et al. Airway complication of expandable stents. Gastrointest Endosc 1999; 49: 136-137